U.S. Markets closed

Tandem Diabetes Care (TNDM) Jumps: Stock Rises 13.1%

Zacks Equity Research

Tandem Diabetes Care, Inc. (TNDM) was a big mover last session, as its shares rose over 13% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This reverses the recent downtrend for the company, as the stock is now down over 14%.

In the last 30 days, the company witnessed one positive estimate revision and the Zacks Consensus Estimate moved higher, suggesting more solid trading ahead. So make sure to keep an eye on this stock going forward to see if yesterday’s jump can turn into more strength down the road.

Tandem Diabetes Care currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Other better-ranked stocks in the med-instruments industry include Accuray Incorporated (ARAY), Alphatec Holdings, Inc. (ATEC) and Heartware International Inc. (HTWR). All three sport a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

ACCURAY (ARAY): Free Stock Analysis Report

ALPHATEC HOLDINGS INC (ATEC): Free Stock Analysis Report


TANDEM DIABETES CARE INC (TNDM): Free Stock Analysis Report

Zacks Investment Research